Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00539045 · ClinicalTrials.gov registry record

Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction

A clinical trial of Myocardial Infarction and Thrombus, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
250
Enrollment target
1
Study location

NCT00539045 is a study of Myocardial Infarction and Thrombus that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 250 participants, below the 4,678-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00539045, a study of Myocardial Infarction and Thrombus, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

This is a cross-sectional study of post myocardial infarction patients which is designed to determine the prevalence of left ventricular thrombi (blood clots) using non-contrast echocardiography and to compare this with the prevalence of left ventricular thrombi using contrast echocardiography. Secondary aims of this study are (1) to identify clinical and imaging correlates of left ventricular thrombi, and (2) to compare quantitative measurements of left ventricular chamber size, function, and myocardial mass using contrast and non-contrast echocardiography.

Study Locations (1)

New York

  • Weill Medical College of Cornell University - New York

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2007-03
Est. Completion 2015-01

What the Registry Record Tells You About NCT00539045

The ClinicalTrials.gov registry entry for NCT00539045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,678-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (95% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.

NCT00539045 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00539045 about?

NCT00539045 is a clinical study titled "Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction". This is a cross-sectional study of post myocardial infarction patients which is designed to determine the prevalence of left ventricular thrombi (blood clots) using non-contrast echocardiography and to compare this with the prevalence of left ventricular thrombi using contrast echocardiography. Seco...

What is the current status of trial NCT00539045?

This trial is currently completed. The enrollment target is 250 participants. The study started on 2007-03. Estimated completion is 2015-01.

What conditions does trial NCT00539045 study?

This clinical trial studies the following conditions: Myocardial Infarction, Thrombus.

Who is sponsoring clinical trial NCT00539045?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00539045 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.